Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RhinoSystems is a medical device company best known for its flagship product, Navage Nasal Care. The company developed the world's first handheld nasal irrigator that utilizes powered suction to flush the nasal cavity, providing relief from congestion and allergies. Unlike traditional gravity-fed systems like neti pots, the Navage system uses a closed-loop suction mechanism to pull saline through the nose. The product is FDA-cleared and widely available through major retail channels and direct-to-consumer platforms. RhinoSystems focuses on non-pharmacological solutions for respiratory hygiene and sinus health. The company's business model includes the sale of the primary device as well as proprietary SaltPod capsules required for operation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Navage.